Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_78587acbfc8d4c9e9ac3baa7021087d7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_991cd4fcd00a0f19d4e1aabbb7bd4202 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S930-224 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-16734 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S424-813 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S424-822 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-245 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-00 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-265 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-245 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00 |
filingDate |
1987-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
1989-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7bafb730287b3b6ff6caa7248c86a37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48ab9de9648358b11b4cf47d6f7567b9 |
publicationDate |
1989-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-4824667-A |
titleOfInvention |
Thymidine kinase deletion mutants of bovine herpesvirus-1, vaccines against infectious bovine rhinotracheitis containing same and methods for the production and use of same |
abstract |
Bovine herpesvirus type 1 (infectious bovine rhinotracheitis virus) mutants which fail to produce any functional thymidine kinase as a result of a deletion in the thymidine kinase gene. The deletion in the thymidine kinase gene attenuates the viruses so that they can be used as an active agent in a modified live-virus vaccine against infectious bovine rhinotracheitis. This invention also relates to methods for the production and use of the same. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5545523-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5451505-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5855902-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6410033-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6221360-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5874279-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6284251-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5593873-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5601816-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0226029-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5763269-A |
priorityDate |
1985-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |